Eppin is a serine protease inhibitor expressed in male reproductive tissues. In this study we have demonstrated novel sites of eppin expression in myeloid and epithelial cell lines with further confirmation in primary myeloid cell types. Using immunohistochemistry and 
Introduction
Human epididymal protease inhibitor (eppin, SPINLW1, WFDC7) is a cysteine-rich protein comprised of both a Kunitz-type and a WAP (whey acidic protein) four-disulfide core (WFDC) protease inhibitor consensus motif [1, 2] . In the epididymis, eppin is secreted by epithelial cells and is a key component in the eppin protein complex which mediates the capacitation of spermatozoa [3] . In this role, eppin acts both as a serine protease inhibitor, inhibiting the action of prostate specific antigen [4] , while protecting the spermatozoa from potential damage by bacteria [3, 5] . The majority of work on eppin to date has therefore focused on the development of eppin as target for a male contraceptive based on inhibition of the eppin protein complex via specific antibodies [6] .
Although eppin is a serine protease inhibitor, the arrangement of cysteine residues differs from that of SLPI and elafin, the two most prominent members of the WFDC family [7] .
Similar to SLPI and elafin, recombinant eppin inhibited elastase activity, but unlike SLPI, eppin had no effect on trypsin or chymotrypsin activities [8] [9] [10] [11] . Split domain studies demonstrated that the serine antiprotease activity resides solely in the Kunitz domain of eppin, while the WFDC domain retains no antiprotease activity [9] . Like SLPI [12] , findings suggest that eppin also possesses antibacterial activity against Escherichia coli and that this effect is mediated via membrane permeabilisation [5] . In contrast to its antiprotease activity, the antibacterial activity of eppin against E. coli appears to be mediated by both the WFDC and Kunitz domains, with maximal killing achieved by the full-length protein [9] . 4 On the basis of their multiple functions, WFDC proteins are considered to play key roles in innate immunity at mucosal surfaces. In contrast to eppin, elafin and SLPI are constitutively expressed by a variety of cell types, including respiratory and intestinal epithelia as well as key cell types involved in the innate immune response such as mast cells, neutrophils, and macrophages [13] [14] [15] [16] [17] [18] [19] . Furthermore, SLPI and elafin expression is altered in response to a number of factors including pro-inflammatory cytokines, bacterial products, proteases and androgens [16, [20] [21] [22] . The anti-inflammatory activity of SLPI and elafin in vitro and in vivo is well documented and reviewed elsewhere [7, 23, 24] . Previous work has shown that SLPI is capable of inhibiting lipopolysaccharide (LPS)-induced responses [20, [25] [26] [27] . In addition, elafin inhibited LPS activation of monocytic cells by inhibiting NF-κB activation via a process partly involving accumulation of polyubiquitinated IκBα [28] . Little is known about the function of eppin outside of the epididymis. In this study, we expand current knowledge on the localisation and regulation of eppin expression, and explore its potential role as a multifunctional host defence protein.
Results

Eppin is expressed in myeloid and airway epithelial cells
Given that SLPI and elafin transcripts are found in a variety of cell types, we first investigated whether eppin had a similar pattern of expression. As expected, eppin expression was detected in testes and lung tissue, albeit to a lesser extent in the lung tissue ( Figure 1A ). Eppin expression was also detected in myeloid cell lines, such as THP-1 and U937 monocytic cells, monocyte-derived macrophages, and neutrophils differentiated from PLB-985 cells ( Figure 1A ). Furthermore, eppin was expressed in both human peripheral blood mononuclear cells (PBMCs) ( Figure 1B ) and polymorphonuclear leucocytes (PMNs) ( Figure 1A ). Expression of eppin was also detected in epithelial cell lines of the respiratory tract including human type-II alveolar cells (A549), as well as tracheal and bronchial epithelial cell lines ( Figure 1B ). Eppin expression was highest in testes expression and, expression of eppin in the other tissues/cells (relative to eppin at 100%) was: THP-1 monocyte (80%), THP-1 macrophage (75%), U937 monocyte (65%), U937 macrophage (55%), PLB-985 cells (57%), PMNs (80%), A549s (39%), lung (47%), PBMCs (24%), HTEs (17%), CFTEs (17%), HBEs (24%) and CFBEs (22%) as determined by densitometry. Sequencing of PCR products confirmed the identity of human eppin.
Detection of eppin in human lung tissue, bronchoalveolar lavage fluid (BALF) and sputum
Human lungs were perfused with LPS as outlined in the Methods section. Tissue samples from non-LPS perfused lobes, LPS-perfused lobes and from cystic fibrosis (CF) patients were used for immunohistochemistry. Some eppin staining was present in non-LPS perfused lung tissue ( Figure 2A ) and was particularly evident in the LPS-perfused ( Figure 2B ) and CF 6 patient ( Figure 2C ) lung tissues. In agreement with the eppin expression data outlined in Figure 1 , positive staining was prominent in epithelial and immune cells using two different eppin antibodies, confirming the presence of eppin in the in vivo lung. In addition, eppin was shown to be present in BALF from patients with Acute Respiratory Distress Syndrome (ARDS) and in sputum from patients with CF but was not present in BALF from healthy volunteers ( Figure 3 ). Eppin was detected as the same high molecular weight complex in ARDS BALF and CF sputum which has been shown previously in semen where eppin is complexed to other proteins including clusterin and lactoferrin 3 . There appears to be low microgram amounts of eppin in CF sputum and ARDS BALF as determined by densitometry of the CF sputum and ARDS BALF blots. Other lower molecular bands were detectable in CF sputum which may represent proteolytic breakdown products of the eppin complex.
Eppin expression and secretion are upregulated by EGF
In order to investigate factors that may affect eppin expression, THP-1 cells were stimulated with a range of inflammatory agonists and effects on eppin expression were assessed by RT-PCR. A number of TLR agonists such as LPS (TLR4), Pam 3 CysSK 4 (TLR2) and polyinosinicpolycytidylic acid (TLR3) had no effect on eppin expression (data not shown). Hormone receptor agonists such as estradiol and progesterone are known inducers of SLPI expression [21, 22] . However, estradiol or progesterone did not modulate eppin expression (data not shown). Growth factors such as epidermal growth factor (EGF) and transforming growth factor-β (TGF-β) have also been shown to regulate SLPI expression [29, 30] . 
Effect of recombinant eppin on bacterial growth
To investigate a potential role for eppin as a host defence protein in the lung, we expressed and purified recombinant human eppin. The ability of eppin to permeabilise clinically relevant Gram negative and Gram positive bacteria as a method of bacterial killing was compared to LL-37, a well-known antimicrobial peptide. Eppin permeabilised P. aeruginosa ( Figure 5A ) and Staphylococcus aureus ( Figure 5B ) bacterial strains and was comparable, if not better than, the permeabilisation observed with LL-37 particularly in the case of P.
aeruginosa. Eppin also inhibited the growth of P. aeruginosa and S. aureus when assessed by radial diffusion assay, once again, with significant effect on P. aeruginosa growth ( Figure   5C ).
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Effect of recombinant eppin on LPS-induced cytokine production
Previous work has shown that the related WFDC proteins, SLPI and elafin, can modulate LPS signalling in monocytic cells [26] [27] [28] . Pre-incubation of THP-1 monocytic cells with eppin for 1 h prior to LPS stimulation significantly inhibited both the expression ( Figure 6A ) and production of IL-8 ( Figure 6B ). In addition, eppin pre-incubation inhibited LPS-induced production of IL-8 from THP-1 monocyte-derived macrophages ( Figure 6C ) and MIP-2 from murine bone marrow-derived macrophages (BMDMs) ( Figure 6D ). We also observed no significant effect of eppin on THP-1 cell viability ( Figure 6E ).
Effects of eppin on NF-κB activation
To investigate further the effect of eppin on the LPS signalling pathway, we evaluated the impact of eppin on LPS-induced activation of NF-κB. Eppin significantly inhibited LPSinduced p65:DNA binding activity in THP-1 nuclear extracts ( Figure 7A ), thereby suggesting that the ability of eppin to inhibit LPS-induced cytokine expression may be mediated via its effects on the NF-κB signalling pathway. SLPI has previously been shown to inhibit LPSinduced NF-κB activity by competing with p65 for binding to consensus sites in the promoter regions of target genes such as IL-8 [27] . However, in contrast to SLPI, eppin was unable to bind NF-κB consensus oligonucleotides ( Figure 7B ). Eppin's effect on LPS signalling upstream of NF-κB was evaluated by Western blotting. LPS-induced degradation of IκBα was observed in samples over time regardless of whether eppin was present or not ( Figure 7C ). However, increased phosphorylation of IκBα was observed in the eppin-treated cells compared to cells treated with LPS alone ( Figure 7C ).
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Eppin inhibits LPS-induced lung neutrophil recruitment in vivo
To determine if eppin might alter LPS effects in vivo, the effects of eppin in an in vivo model of LPS-induced acute lung inflammation were investigated. Mice receiving eppin exhibited a significant reduction in pulmonary total cell counts following intratracheal LPS administration ( Figure 8A ) with a significant decrease in neutrophil counts ( Figure 8B ). This decrease in neutrophil infiltration was associated with a reduction in levels of the neutrophil chemoattractant MIP-2 in BAL fluid from mice that received eppin and LPS compared to LPS alone ( Figure 8C ). These data confirm the in vitro findings for MIP-2 shown in Figure 5D and suggest that eppin may play an immunomodulatory role in the airways by reducing LPSinduced MIP-2 production from host cells with a subsequent reduction in neutrophil recruitment.
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Discussion
The majority of work on eppin to date has focused on its role within the male reproductive hormone receptor agonists and cytokine stimuli used in this study.
These findings are similar to those reported for HE4 (WFDC2), another WFDC family member. HE4 was originally thought to be limited to the reproductive tract however, the expression profile of HE4 has since expanded to include the trachea, lung and nasal epithelium as well as major and minor salivary glands [13, 31] . HE4 expression was not affected by pro-inflammatory agonists such as IL-1β and TNF-α [14] . Although SLPI expression is induced by hormone receptor agonists such as estradiol and progesterone, elafin expression is unaffected [21, 22] . In addition, growth factors have been shown to regulate SLPI expression in vitro and in vivo [29, 30, 32] . In this study, eppin expression in monocytic cells was unaffected by estradiol and progesterone treatment (data not shown), however, both eppin expression and secretion were up-regulated by EGF treatment. We have also provided evidence of eppin protein in the lungs of patients with Cystic Fibrosis and 11 ARDS by immunohistochemistry and Western blot indicating that eppin is increased during inflammation with little eppin present in healthy lung. It should be highlighted that further confirmation of eppin presence in diseased lung could be provided by the availability of more specific monoclonal antibodies to eppin as there is a paucity of eppin antibodies available to carry out definitive in vivo studies. However, our immunohistochemistry and Western blot data does correlate to the eppin expression detected in lung epithelial and inflammatory cells as shown in Figure 1 . Eppin was not detected as a monomeric species in CF and ARDS airway secretions but was present as a high molecular weight complex or oligomeric species in these biological fluids which has been shown previously in semen where eppin is complexed to other proteins including clusterin and lactoferrin 3 .
For the purposes of investigating a potential host defence role for eppin, we expressed and purified recombinant eppin [9] . Our subsequent analyses focused on exploring the antibacterial and immunomodulatory potential of eppin. Recombinant eppin has previously been shown to inhibit growth of E. coli [5, 9] . In this study, we expand these observations by demonstrating an antibacterial effect of eppin against P. aeruginosa and S.aureus, two clinically relevant pulmonary pathogens. Although there are limitations associated with the radial diffusion assay, the bacterial membrane permeabilisation assay provides more definitive anti-bacterial activity data and the combined results of both assays serve to confirm that eppin has a greater effect on P. aeruginosa than S.aureus. In order to investigate the immunomodulatory effects of eppin, our studies focussed on the effects of 
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Recombinant protein production
Recombinant eppin was produced as described previously [9] .
RNA extraction and RT-PCR
RNA from human lung, testes tissue, primary peripheral blood mononuclear (PBMC) and polymorphonuclear leucocytes (PMN) cells were purchased from BioChain (Hayward, California, USA).
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Analysis of secreted eppin
THP-1 monocytic cells were incubated in serum free media for 8 h in the absence or presence of EGF (5 ng/ml; Peprotech, London, UK). Supernatants were collected and protein precipitated using a method adapted from Wessel and Fugge [35] .
Human lung tissue
Lungs harvested from potential donors that were found to be unsuitable for transplantation were perfused ex vivo based on previously described methods [36, 37] . Experimentation ceased 4 hr after LPS instillation, upon which tissue samples for histology were taken from LPS-perfused lobes [36] . Lung tissue sections from CF patients were obtained from the University of Newcastle. Ethical approval for the use of these tissue samples was obtained from Newcastle and North Tyneside Ethics Committee (reference number 11/NE/0291).
Immunostaining of human tissue for eppin
Immunostaining for eppin detection was performed similar to previous methods [36] .
Effect of recombinant eppin in a murine model of LPS-induced lung inflammation
C57Bl/6 mice (10 -12 weeks of age) were used in all experiments and were purchased from
Charles Rivers Laboratories and also bred in-house.
Statistical analysis
All data were analysed using GraphPad Prism 5.0 (GraphPad Software Inc., San Diego, CA). n = 3 -7/group, ** P < 0.01, *** P < 0.001 vs LPS. 
